Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.
This retraction was approved by the Chief Editors of Frontiers in Immunology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.
Summary
Keywords
Natural Killer, Pancreatic Cancer, Exosomes, miR-3607-3p, IL-26
Citation
Frontiers Editorial Office (2024) Retraction: Natural killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26. Front. Immunol. 15:1480124. doi: 10.3389/fimmu.2024.1480124
Received
13 August 2024
Accepted
13 August 2024
Published
19 August 2024
Approved by
Luigi Daniele Notarangelo, National Institute of Allergy and Infectious Diseases (NIH), United States
Volume
15 - 2024
Updates
Copyright
© 2024 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.